Last week Max International attended the 1st International Conference of Medical Biology and 3rd International Symposium of Biological Therapies and Homotoxicology in Buenos Aires, Argentina to present on RiboCeine™ and glutathione. What’s remarkable about this event was that Max was specifically invited by the president of the Argentinean Medical Associates (AMA) to talk about its breakthrough technology with doctors from Colombia, Venezuela, Brazil, Mexico, Spain, and other locations from around the world.
We were proud to send Dr. Herb Nagasawa, the creator of RiboCeine, to present on the science behind this breakthrough technology as part of the “New Paradigms in the Diagnosis and Treatments of Disabilities” program. Dr. Nagasawa was honored to give his talk on Friday and then an encore talk during the keynote presentation on the final day. His presentation was immediately followed by a one-hour Q & A that had the attending doctors buzzing with excitement. Everyone in attendance was fascinated by the science of RiboCeine, the Max products, and their varied uses.
Also attending the event was Max’s product development team, the Executive Director of Product Development Scott Nagasawa, Pharm.D. and the Executive Director of Product Management Scott Momii. Scott Nagasawa gave a presentation titled “Free Radicals, Oxidative Stress, Glutathione and RiboCeine” that helped situate the important role that RiboCeine plays in improving our glutathione development. Overall he was very impressed with the sincerity and interest of the international community during the symposium and greatly appreciated the professionalism displayed by their handlers and translators.
Scott Momii noted that their personal translator had taken the time to study all of Dr. Nagasawa’s previous talks on YouTube to ensure that they had all the terminology correct! Dr. Nagasawa was a major name at the symposium and every one in attendance was awed by his accomplishments.
Joe Voyticky, Max International’s Co-CEO, also attended the event and came away with a renewed passion for how our company can impact the world. He noted that “it all became real for him” when he approached the front doors of the AMA’s headquarters, that this was to be a major watershed moment for the company and its products. He’s impressed by just how dynamic the opportunity for Max is in Latin and South America, and how much real promise this region of the world has for the future of our company.
Joe will talk more about his impressions of the conference and what this means for the company during the November 17th Saturday Conference Call at 10:00 a.m. MST.
The invitation to this event proves that RiboCeine truly is a breakthrough technology and that Max International is at the forefront of this movement. We want our Associates to know that it’s your work and determination that’s bringing the power and promise of Max to all corners of the globe. You all can take pride in the achievements we’ve made and the bright future we have ahead of us!